|
Temps Différé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 913,75 INR | -0,52% |
|
-3,33% | +1,16% |
| 18/07 | Natco Pharma Limited reçoit une approbation provisoire de la FDA pour ses comprimés d'Olaparib | CI |
| 14/07 | NATCO Pharma acquiert une participation supplémentaire de 13 % dans Adcock Ingram | MT |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0,52% | -3,33% | +2,23% | -16,43% | +1,16% | -8,56% | +18,68% | -13,60% | +51,84% | 1,7 Md | |
| +1,97% | +1,43% | +7,12% | +29,23% | +10,35% | +48,44% | +156,66% | +385,71% | +1 353,45% | 1 057 Md | |
| +1,42% | +3,72% | +8,44% | +12,41% | +25,28% | +53,32% | +52,34% | +50,92% | +107,37% | 624 Md | |
| +1,43% | +0,99% | +9,44% | +27,85% | +12,44% | +34,83% | +78,74% | +117,38% | +302,63% | 454 Md | |
| +5,14% | +5,40% | +7,47% | +7,57% | +6,49% | +33,75% | +27,28% | +0,63% | +39,91% | 341 Md | |
| +1,85% | +3,57% | +3,44% | +9,79% | +16,48% | +37,09% | +39,87% | +50,95% | +55,02% | 297 Md | |
| -0,11% | +0,48% | -6,64% | -12,45% | -7,99% | +18,87% | +17,81% | +49,62% | +175,08% | 262 Md | |
| +0,25% | -4,62% | +4,08% | +29,83% | -1,52% | -27,66% | -42,25% | +12,21% | +70,83% | 215 Md | |
| +1,49% | -0,02% | +7,06% | +6,56% | +13,50% | +20,14% | +58,21% | +49,97% | +124,24% | 201 Md | |
| +0,40% | -3,99% | +4,65% | -2,08% | +6,62% | +15,23% | +62,28% | +89,60% | +51,20% | 162 Md | |
| +0,77% | -0,52% | +1,17% | -6,22% | +0,44% | -1,38% | -33,13% | -40,00% | -31,93% | 143 Md | |
| +1,23% | +1,65% | +10,77% | +4,22% | +14,03% | +25,58% | -4,90% | -9,99% | -18,72% | 126 Md | |
| +0,11% | -2,66% | +1,00% | +8,73% | +4,35% | -0,81% | +30,52% | +135,96% | +403,88% | 120 Md | |
| -0,62% | -0,75% | +3,93% | -6,60% | -7,69% | -9,79% | -22,56% | -13,30% | -0,31% | 104 Md | |
| -0,26% | -2,58% | -2,66% | -8,21% | +4,44% | +38,94% | +37,26% | +7,66% | -8,14% | 101 Md | |
| +3,49% | +1,91% | -0,47% | -15,60% | -9,44% | +3,14% | +83,46% | +78,76% | +474,97% | 72,43 Md | |
| -.--% | +1,73% | - | - | - | - | - | - | - | 63,66 Md | |
| +2,45% | +2,92% | +10,50% | +5,72% | +16,65% | +29,66% | +27,92% | +52,43% | +23,52% | 53,64 Md | |
| -0,87% | -1,93% | +12,11% | -2,64% | -7,82% | -3,89% | +19,55% | -10,70% | +251,42% | 53,47 Md | |
| -1,64% | -3,19% | +19,69% | +15,38% | +24,83% | +62,25% | -11,05% | -9,77% | -49,82% | 51,61 Md | |
| Moyenne | +0,96% | +0,08% | +5,44% | +4,58% | +6,45% | +19,43% | +31,40% | +51,81% | +177,71% | 225,2 Md | |
| Moyenne pondérée par Capi. | +1,51% | +1,19% | +5,84% | +13,49% | +9,89% | +31,30% | +63,14% | +127,17% | +416,02% |
- Bourse
- Actions
- Action NATCOPHARM
- Secteur NATCO Pharma Limited
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
